Rational design of environmentally responsive antibodies with pH-sensing synthetic amino acids

Antibodies are widely used as therapeutic agents to tackle various diseases. In the present study, to enhance their clinical values, we rationally designed pH-responsivity by exploiting the idiosyncratic protonation/deprotonation profiles of non-natural amino acids. 3-Nitro- l -tyrosine, 3-cyano- l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2024-08, Vol.14 (1), p.19428-11
Hauptverfasser: Isoda, Yuya, Ohtake, Kazumasa, Piao, Wen, Oashi, Taiji, Kiku, Fumika, Uchida, Aiko, Ikeda, Masahiro, Masuda, Kazuhiro, Sakamoto, Kensaku, Shiraishi, Yasuhisa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antibodies are widely used as therapeutic agents to tackle various diseases. In the present study, to enhance their clinical values, we rationally designed pH-responsivity by exploiting the idiosyncratic protonation/deprotonation profiles of non-natural amino acids. 3-Nitro- l -tyrosine, 3-cyano- l -tyrosine, and 3, 5-halogenated- l -tyrosine, each with near neutral pK a , were thus incorporated into Fab fragments in place of tyrosines and other residues in the variable regions. Cell-based assays showed that these modifications achieved up to 140-fold tighter binding to antigens and several-fold tighter cytotoxicity to antigen-expressing cell at pH 6.0 than pH 7.4. The pH-dependent binding effect was retained in full-length antibodies. In silico structural analyses revealed electrostatic repulsion at neutral pH between antigens and antibodies or inside the antibody as the underlying mechanisms of the acid preference, and this finding increases the designability of pH-dependent antigen binding. The development of antibodies responsive to the microenvironments of diseased tissues will allow more disease-related antigens to be targeted in treatments, because of the reduced cross-reactivity toward healthy tissues.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-70271-3